Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG CLASS:

CDK7 inhibitor

DRUG CLASS:

CDK7 inhibitor

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Related drugs:

No biomarker	Triple Negative Breast Cancer	No biomarker	Triple Negative Breast Cancer	CT7001 Sensitive: B - Late Trials CT7001 Sensitive : B	CT7001 Sensitive: B - Late Trials CT7001 Sensitive : B
HR positive	HER2 Negative Breast Cancer	HR positive	HER2 Negative Breast Cancer	CT7001 Sensitive: B - Late Trials CT7001 Sensitive : B	CT7001 Sensitive: B - Late Trials CT7001 Sensitive : B
HR positive	HER2 Negative Breast Cancer	HR positive	HER2 Negative Breast Cancer	SY-5609 Sensitive: C2 – Inclusion Criteria SY-5609 Sensitive : C2	SY-5609 Sensitive: C2 – Inclusion Criteria SY-5609 Sensitive : C2
HR positive	Hormone Receptor Positive Breast Cancer	HR positive	Hormone Receptor Positive Breast Cancer	CT7001 Sensitive: C3 – Early Trials CT7001 Sensitive : C3	CT7001 Sensitive: C3 – Early Trials CT7001 Sensitive : C3
CDK7 overexpression	Cholangiocarcinoma	CDK7 overexpression	Cholangiocarcinoma	SY‑079 Sensitive: D – Preclinical SY‑079 Sensitive : D	SY‑079 Sensitive: D – Preclinical SY‑079 Sensitive : D
MYC amplification	Triple Negative Breast Cancer	MYC amplification	Triple Negative Breast Cancer	YPN-005 Sensitive: D – Preclinical YPN-005 Sensitive : D	YPN-005 Sensitive: D – Preclinical YPN-005 Sensitive : D
MYC amplification	Hepatocellular Cancer	MYC amplification	Hepatocellular Cancer	YPN-005 Sensitive: D – Preclinical YPN-005 Sensitive : D	YPN-005 Sensitive: D – Preclinical YPN-005 Sensitive : D
MYC amplification	Estrogen Receptor Positive Breast Cancer	MYC amplification	Estrogen Receptor Positive Breast Cancer	YPN-005 Sensitive: D – Preclinical YPN-005 Sensitive : D	YPN-005 Sensitive: D – Preclinical YPN-005 Sensitive : D
MYC amplification	Pancreatic Cancer	MYC amplification	Pancreatic Cancer	YPN-005 Sensitive: D – Preclinical YPN-005 Sensitive : D	YPN-005 Sensitive: D – Preclinical YPN-005 Sensitive : D
MYC amplification	Prostate Cancer	MYC amplification	Prostate Cancer	YPN-005 Sensitive: D – Preclinical YPN-005 Sensitive : D	YPN-005 Sensitive: D – Preclinical YPN-005 Sensitive : D
MYC amplification	Small Cell Lung Cancer	MYC amplification	Small Cell Lung Cancer	YPN-005 Sensitive: D – Preclinical YPN-005 Sensitive : D	YPN-005 Sensitive: D – Preclinical YPN-005 Sensitive : D
MYC amplification	Ovarian Cancer	MYC amplification	Ovarian Cancer	YPN-005 Sensitive: D – Preclinical YPN-005 Sensitive : D	YPN-005 Sensitive: D – Preclinical YPN-005 Sensitive : D